Search results for "Atrial fibrillation"
New studies analyze risk factors, treatments for afib
One study found that early rhythm control was better than rate control for low-risk patients, another found that age at menarche and menopause was associated with afib risk, and another indicated that women's lower risk for afib is due to their smaller body size compared with men.
https://immattersacp.org/weekly/archives/2022/09/06/1.htm
6 Sep 2022
Point-of-care screening did not affect diagnosis of afib in primary care, study finds
In a randomized trial at 16 primary care clinics in Massachusetts, rates of new afib diagnosis at one year were 1.72% with afib screening of older patients using a single-lead electrocardiogram versus 1.59% with usual care.
https://immattersacp.org/weekly/archives/2022/03/08/1.htm
8 Mar 2022
Review suggests optimal dose of omega-3 fatty acids for reducing blood pressure
The optimal intake for both systolic and diastolic blood pressure reduction is 2 to 3 g/d, according to a dose-response meta-analysis of 71 randomized controlled trials, although an editorial said omega-3s “are still not fully ready for prime time.”
https://immattersacp.org/weekly/archives/2022/06/07/2.htm
7 Jun 2022
Cardiac societies issue new joint guideline on management of heart failure
The updated guideline recommends sodium-glucose cotransporter-2 inhibitors for many heart failure patients, regardless of their diabetes status, among other changes.
https://immattersacp.org/weekly/archives/2022/04/05/2.htm
5 Apr 2022
Intervention targeting clinicians did not increase anticoagulation use in patients with afib
Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
https://immattersacp.org/weekly/archives/2020/02/25/4.htm
25 Feb 2020
Apixaban associated with lower risk of GI bleeding compared to other DOACs
Apixaban users experienced similar rates of ischemic stroke or systemic embolism, intracranial hemorrhage, and all-cause mortality as patients taking other direct oral anticoagulants (DOACs), a retrospective analysis found.
https://immattersacp.org/weekly/archives/2022/11/01/1.htm
1 Nov 2022
Apixaban may be safer, more effective than rivaroxaban for afib
Patients taking rivaroxaban had higher rates of stroke or systemic embolism and gastrointestinal or brain bleeding compared to those taking apixaban, according to a retrospective cohort study.
https://immattersacp.org/weekly/archives/2020/03/10/4.htm
10 Mar 2020
DOACs show better safety, effectiveness than warfarin in patients with valvular afib
As a class, direct oral anticoagulants (DOACs) were associated with lower risk for ischemic stroke or systemic embolism and major bleeding events than warfarin, and results were consistent for apixaban and rivaroxaban.
https://immattersacp.org/weekly/archives/2021/03/30/1.htm
30 Mar 2021
Inappropriate medications prescribed in some Medicare patients with CKD, study finds
Over a third of patients with chronic kidney disease (CKD) enrolled in a Medicare plan's Medication Therapy Management program in 2018 received a prescription for at least one potentially inappropriate medication.
https://immattersacp.org/weekly/archives/2021/02/02/5.htm
2 Feb 2021
Scientific statement addresses primary care's role in poststroke care
Effective communication by primary care clinicians can improve adherence to necessary interventions after stroke, boost patient motivation, and reduce barriers to care, the American Heart Association and American Stroke Association advised.
https://immattersacp.org/weekly/archives/2021/07/27/2.htm
27 Jul 2021